1 min read
Add as a preferred source on GoogleTScan Therapeutics Q3 Revenue Falls 76.7% to $586,000
The company recorded a GAAP loss of $0.25 per share for the quarter.
TScan Therapeutics, Inc. posted $586,000 in revenue for the third quarter, down 76.7% from a year earlier, while it recorded a GAAP loss of $0.25 per share.
Revenue in the year-earlier quarter was $2.511 million.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.